US 11160779
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted A61KA61K31/27A61K31/325
Quick answer
US patent 11160779 (Methods of providing solriamfetol therapy to subjects with impaired renal function) held by Jazz Pharmaceuticals Ireland Limited expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jazz Pharmaceuticals Ireland Limited
- Grant date
- Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/27, A61K31/325, A61K9/0053, A61P